Form 4: Abbott Laboratories Director Gonzalez Reports Acquisition of Restricted Stock Units

Director Patricia Paola Gonzalez reports the acquisition of restricted stock units in Abbott Laboratories under the 2017 Incentive Stock Program.

Summary

• Patricia Paola Gonzalez, a director of Abbott Laboratories, filed a Form 4 on April 29, 2025.
• The report details the acquisition of 1,635 common shares without par value on April 25, 2025, under the Abbott Laboratories 2017 Incentive Stock Program.
• These shares are restricted stock units that will be paid in Abbott common shares on a one-to-one basis upon separation from service, death, or a change in control.
• Following the transaction, Gonzalez directly owns 6,919 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it is a standard disclosure of stock units granted to a director. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

• The acquisition of restricted stock units indicates confidence in the company's future performance.

Future Outlook

The restricted stock units will be paid out in Abbott common shares upon the director's separation from service, death, or a change in control, as defined in the 2017 Incentive Stock Program.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in their own company's stock. This allows investors to monitor insider activity, which can sometimes provide insights into management's view of the company's prospects.

Stakeholder Impact

• The acquisition of restricted stock units by a director may have a minor positive impact on shareholder confidence.

Key Dates

Keywords

Form 4, Abbott Laboratories, Director, Gonzalez, Restricted Stock Units, ABT, Incentive Stock Program, Beneficial Ownership